UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Xerox
XRX
$427M
| $2.31M | ﹤0.01% |
176,444
-41,202
| -19% | -$667K |
|
1477
Progress Software
PRGS
$1.78B
| $2.31M | ﹤0.01% |
54,217
-11,836
| -18% | -$547K |
|
|
FOLD
1478
DELISTED
Amicus Therapeutics
FOLD
| $2.31M | ﹤0.01% |
220,894
-50,585
| -19% | -$564K |
|
1479
Pacira BioSciences
PCRX
$974M
| $2.3M | ﹤0.01% |
43,192
-10,735
| -20% | -$597K |
|
1480
Transocean
RIG
$6.39B
| $2.29M | ﹤0.01% |
927,586
-210,733
| -19% | -$674K |
|
1481
Nu Skin
NUS
$250M
| $2.29M | ﹤0.01% |
68,634
+5,436
| +9% | +$226K |
|
1482
Graham Holdings Company
GHC
$4.99B
| $2.29M | ﹤0.01% |
4,248
-708
| -14% | -$405K |
|
1483
FirstCash
FCFS
$9.05B
| $2.28M | ﹤0.01% |
31,127
-7,726
| -20% | -$576K |
|
|
TPH
1484
DELISTED
Tri Pointe Homes
TPH
| $2.28M | ﹤0.01% |
150,612
-15,692
| -9% | -$277K |
|
|
VRNT
1485
DELISTED
Verint Systems
VRNT
| $2.27M | ﹤0.01% |
67,716
-8,842
| -12% | -$385K |
|
1486
Banner Corp
BANR
$2.43B
| $2.27M | ﹤0.01% |
38,436
+227
| +0.6% | +$13.7K |
|
1487
HUB Group
HUBG
$2.9B
| $2.27M | ﹤0.01% |
65,716
-15,976
| -20% | -$610K |
|
1488
Hope Bancorp
HOPE
$1.79B
| $2.26M | ﹤0.01% |
179,187
-12,635
| -7% | -$183K |
|
1489
Genworth Financial
GNW
$3.7B
| $2.26M | ﹤0.01% |
647,091
-28,586
| -4% | -$115K |
|
|
ALTR
1490
DELISTED
Altair Engineering Inc
ALTR
| $2.26M | ﹤0.01% |
51,121
-9,340
| -15% | -$490K |
|
1491
Alight
ALIT
$394M
| $2.26M | ﹤0.01% |
15,412
+1,722
| +13% | +$266K |
|
1492
J&J Snack Foods
JJSF
$1.68B
| $2.25M | ﹤0.01% |
17,341
-3,893
| -18% | -$553K |
|
1493
First Merchants
FRME
$2.66B
| $2.24M | ﹤0.01% |
58,010
-16,208
| -22% | -$643K |
|
|
VISN
1494
Vistance Networks Inc
VISN
$2.63B
| $2.24M | ﹤0.01% |
243,148
-9,116
| -4% | -$87.4K |
|
1495
Hecla Mining
HL
$11.8B
| $2.24M | ﹤0.01% |
567,701
-141,651
| -20% | -$576K |
|
1496
Schwab US TIPS ETF
SCHP
$16.2B
| $2.23M | ﹤0.01% |
+86,236
| New | +$2.4M |
|
1497
Red Rock Resorts
RRR
$3.62B
| $2.23M | ﹤0.01% |
65,080
-15,367
| -19% | -$583K |
|
1498
Dorman Products
DORM
$3.95B
| $2.23M | ﹤0.01% |
27,112
-5,773
| -18% | -$569K |
|
1499
Moelis & Co
MC
$4.72B
| $2.22M | ﹤0.01% |
65,686
-10,714
| -14% | -$449K |
|
1500
Piper Sandler
PIPR
$5.29B
| $2.2M | ﹤0.01% |
84,048
-2,460
| -3% | -$71.6K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.